Evidence mapPaperPMID 41170710Full record

ReviewJournal of neurochemistry2025

RNA Granules at the Crossroads of Synaptic Dysfunction and Neurodegeneration.

Rita Nóbrega-Martins, Beatriz Barros-Santos, Georgia Papadimitriou, Ioannis Sotiropoulos, Benjamin Wolozin, Joana Margarida Silva

Abstract readReview
In one paragraph

Review in Journal of neurochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Pharmacological modulation of stress granulesFrontiers in pharmacology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rita Nóbrega-MartinsLife and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Campus Gualtar, Braga, Portugal.ORCID 0000-0002-1364-6404
Beatriz Barros-SantosLife and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Campus Gualtar, Braga, Portugal.ORCID 0000-0002-5056-1629
Georgia PapadimitriouLife and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Campus Gualtar, Braga, Portugal.ORCID 0000-0003-4892-992X
Ioannis SotiropoulosInstitute of Biosciences & Applications NCSR "Demokritos", T.Patriarchou Grigoriou & Neapoleos, Athens, Greece.ORCID 0000-0003-0115-0038
Benjamin WolozinDepartment of Pharmacology & Experimental Therapeutics, School of Medicine, Boston University, Boston, Massachusetts, USA.ORCID 0000-0003-2068-1475
Joana Margarida SilvaLife and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Campus Gualtar, Braga, Portugal.ORCID 0000-0002-8257-3413

Funding

Fundação para a Ciência e a Tecnologia 2021.00204.CEECCINDFundação para a Ciência e a Tecnologia 2024.00916.BDFundação para a Ciência e a Tecnologia LA/P/0050/2020 (DOI 10.54499/LA/P/0050/2020)Fundação para a Ciência e a Tecnologia UID/06304/2023
6 · The paper itself

Abstract

RNA granules are dynamic, membraneless organelles essential for the spatial and temporal regulation of mRNA metabolism, particularly in neurons, where local protein synthesis supports synaptic plasticity and function. This review explores the diverse types of RNA granules (e.g., transport granules, stress granules, and processing bodies), their formation mechanisms, molecular composition, and relevance to synaptic physiology. We focus on the central role of RNA-binding proteins (RBPs) in orchestrating granule dynamics and their fine-tuning of synaptic responses under both physiological and stress conditions. Mounting evidence implicates the dysfunction of RNA granules in neurodegenerative diseases. Altered phase separation, RBP aggregation, and persistent stress granules contribute to the formation of pathological RNA granules that interfere with local translation and synaptic maintenance. Key RBPs, including TDP-43, FUS, and TIA-1, are frequently misregulated in disease contexts. Furthermore, Tau is a multifunctional protein traditionally associated with microtubule stabilization but is increasingly recognized for its role in the translational stress response, which includes RBP mislocalization and RNA granule disruption. We examine how chronic stress can exacerbate these mechanisms, acting as an environmental trigger of synaptic vulnerability associated with neurodegeneration. In summary, we explore a conceptual framework connecting RNA granule dysregulation, Tau pathology, and local translation disruption, three processes that converge on synaptic impairment, a central feature of many neurodegenerative diseases characterized by abnormal Tau. Investigating this triad presents a promising avenue for understanding disease mechanisms and identifying novel therapeutic targets that aim to restore RNA metabolism, prevent toxic Tau interactions, and preserve synaptic health.

Indexed as

Cytoplasmic GranulesNeurodegenerative DiseasesRNASynapsesAnimalsHumansRNA-Binding ProteinsStress GranulesRNARNA-Binding ProteinsneurodegenerationRNA‐binding proteinsstress granulessynaptic dysfunctiontau pathology

Identifiers

PMID41170710
PMCPMC12576883

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.